- Home
- MFM vs ARAY Comparison
MFM vs ARAY Comparison
Compare MFM & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFM
- ARAY
- Stock Information
- Founded
- MFM 1986
- ARAY 1990
- Country
- MFM United States
- ARAY United States
- Employees
- MFM N/A
- ARAY N/A
- Industry
- MFM Finance Companies
- ARAY Medical/Dental Instruments
- Sector
- MFM Finance
- ARAY Health Care
- Exchange
- MFM Nasdaq
- ARAY Nasdaq
- Market Cap
- MFM 209.6M
- ARAY 229.3M
- IPO Year
- MFM N/A
- ARAY 2007
- Fundamental
- Price
- MFM $5.11
- ARAY $1.55
- Analyst Decision
- MFM
- ARAY
- Analyst Count
- MFM 0
- ARAY 0
- Target Price
- MFM N/A
- ARAY N/A
- AVG Volume (30 Days)
- MFM 108.1K
- ARAY 661.7K
- Earning Date
- MFM 01-01-0001
- ARAY 04-30-2025
- Dividend Yield
- MFM 4.08%
- ARAY N/A
- EPS Growth
- MFM N/A
- ARAY N/A
- EPS
- MFM 0.03
- ARAY 0.01
- Revenue
- MFM N/A
- ARAY $465,251,000.00
- Revenue This Year
- MFM N/A
- ARAY $3.87
- Revenue Next Year
- MFM N/A
- ARAY $0.09
- P/E Ratio
- MFM $176.67
- ARAY $231.84
- Revenue Growth
- MFM N/A
- ARAY 8.06
- 52 Week Low
- MFM $4.37
- ARAY $1.28
- 52 Week High
- MFM $5.48
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- MFM 41.87
- ARAY 47.74
- Support Level
- MFM $5.08
- ARAY $1.53
- Resistance Level
- MFM $5.14
- ARAY $1.77
- Average True Range (ATR)
- MFM 0.06
- ARAY 0.08
- MACD
- MFM -0.00
- ARAY -0.00
- Stochastic Oscillator
- MFM 28.95
- ARAY 21.43
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.